Not applicableStudy completedNCT00707629What this trial is testingLong Term Effects of Diabetes of Very Young ChildrenWho this might be right forType 1 Diabetes Indiana University 25
Not applicableStudy completedNCT05746845What this trial is testingImplication of 5-HT7 Receptor in Inflammatory Mechanisms in Multiple SclerosisWho this might be right forHealthyMultiple Sclerosis Centre Hospitalier Régional d'Orléans 100
Large-scale testing (Phase 3)Study completedNCT01874145What this trial is testingSafety and Tolerability of Glatiramer AcetateWho this might be right forRelapsing-Remitting Multiple Sclerosis Teva Branded Pharmaceutical Products R&D, Inc. 209
Not applicableActive Not RecruitingNCT07028879What this trial is testingEffectiveness of a One-year Group Program for Fatigue Management in Minimally Impaired People With Multiple SclerosisWho this might be right forMultiple Sclerosis Hospital Clinic of Barcelona 24
Very early researchUnknownNCT05353179What this trial is testingStudy on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male VolunteersWho this might be right forGranulomatosis With PolyangiitisHemophagocytic Syndrome Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 88
Not applicableStudy completedNCT03244696What this trial is testingBehavior and Activity Monitoring in MSWho this might be right forRelapsing-Remitting Multiple Sclerosis Ohio State University 87
Early research (Phase 1)Study completedNCT00652288What this trial is testingEvaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin AnalogsWho this might be right forDiabetes Mellitus, Type I Yale University 36
Testing effectiveness (Phase 2)Study completedNCT07461103What this trial is testingEffect of Topical Insulin on Healing Rate of Pemphigus LesionsWho this might be right forPemphigus VulgarisSkin ErosionAutoimmune Blistering Disease Alexandria University 20
Post-approval studies (Phase 4)Study completedNCT01010503What this trial is testingTocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 32
Testing effectiveness (Phase 2)WithdrawnNCT00850161What this trial is testingIntranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous InsulinWho this might be right forType 1 Diabetes Mellitus CPEX Pharmaceuticals Inc.
Large-scale testing (Phase 3)Study completedNCT00773461What this trial is testingTocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 209
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05459870What this trial is testingCAR-T Cells Targeting Autoimmune DiseasesWho this might be right forAutoimmune Diseases Shenzhen Geno-Immune Medical Institute 30
Not applicableStudy completedNCT03950583What this trial is testingThe Clinical Course of Interstitial Pneumonia With Autoimmune FeaturesWho this might be right forInterstitial Pneumonia London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 68
Not applicableEnded earlyNCT04909983What this trial is testingAn Explorative Study of Treatment of Contact Dermatitis Due to DiabetesDevicesWho this might be right forContact Dermatitis IrritantType 1 Diabetes Copenhagen University Hospital at Herlev 17
Not applicableStudy completedNCT00617383What this trial is testingAT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MSWho this might be right forMultiple SclerosisClinically Isolated Syndrome The University of Texas Health Science Center, Houston 3
Not applicableStudy completedNCT04071405What this trial is testingKorea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis PatientsWho this might be right forUlcerative Colitis Pfizer 110
Early research (Phase 1)Study completedNCT02583594What this trial is testingCharacterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple SclerosisWho this might be right forProgressive Multiple Sclerosis Genzyme, a Sanofi Company 24
Not applicableStudy completedNCT03993366What this trial is testingPramlintide and Fiasp Closed-Loop With a Simple Meal AnnouncementWho this might be right forType 1 Diabetes Mellitus McGill University 8
Testing effectiveness (Phase 2)Study completedNCT01754337What this trial is testingClosed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 DiabetesWho this might be right forType 1 Diabetes Institut de Recherches Cliniques de Montreal 30
Testing effectiveness (Phase 2)Study completedNCT04838145What this trial is testingThe Diabetes Virus Detection and Intervention TrialWho this might be right forType1 Diabetes MellitusEnterovirus Oslo University Hospital 96